ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
2 2025
Изменен: 30.04.2025Путь: Главная / Публикации
ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
11401 11402 11403 11404 11405 11406 9644 11291 11407 11408 7666 11409 11410 11411 11412 2 2025
Изменен: 30.04.2025Путь: Главная / Басты бет / Жарияланымдар
ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
... viral hepatitis and its complications. The development of pangenotypic direct-acting antivirals (DAAs) has significantly improved the prognosis of hepatitis C virus (HCV) infection in this population. However, local data from Central Asia, particularly Kazakhstan, remain limited. Aim: To evaluate the efficacy and safety of antiviral therapy in a subgroup of 12 patients with chronic hepatitis B and/or C receiving maintenance hemodialysis at the Hepato Center in Almaty. Methods: From a larger cohort of 164 hemodialysis patients with confirmed viral hepatitis, 12 patients received antiviral treatment between 2021 and 2023. Treatment regimens included pangenotypic DAAs for HCV ...
Изменен: 30.04.2025Путь: Главная / Home / Publications
Результаты поиска 1 - 3 из 3
Начало | Пред. | 1 | След. | Конец
Сортировать по релевантности | Отсортировано по дате